Postoperative Cognitive Dysfunction Completed Phase 4 Trials for Rivastigmine (DB00989)

IndicationStatusPhase
DBCOND0036861 (Postoperative Cognitive Dysfunction)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00835159Rivastigmine in the Treatment of Postoperative Delirium: a Pilot Clinical TrialPrevention